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Learning objectives
The aim of our work is to discuss the clinical and technical eligibility for MRgFUS of
women with symptomatic uterine fibroids emphasizing the lack of knowledge of this
technique among both patients and physicians.
Background
Uterine leiomyomas are the most common benign tumor in women of childbearing
age. Approximately 25% of women with fibroids experience symptoms such as heavy
bleeding, pelvic pain, and pregnancy complications.
To date both medical and surgical approaches for fibroids treatment are available.
Uterine-sparing technics, such as myomectomy and uterine artery embolization (UAE),
are usually preferred by women of childbearing age.
MRgFUS represents a feasible, effective, and completely non-invasive thermal ablation
procedure that may be alternatively used as a fertility-preserving technique in selected
cases. It was approved by the European Community (CE) in 2002 and by the Food
and Drug Administration (FDA) in 2004. To date, no absolute inclusion criteria have
been defined to establish treatment indications and most cases are referred for MRgFUS
treatment after many clinical and imaging examinations.
Findings and procedure details
From June 2012 to August 2013, 29 outpatients' women (mean age 43.14±5.96 years)
with symptomatic uterine fibroids were considered clinically eligible for MRgFUS by a
general practitioner or a gynecologist and underwent pretreatment pelvic MR through a
1.5-T MRI scanner before and after i.v. medium contrast injection to determine candidacy
for the procedure.
Most frequent reasons for ineligibility were: thickness of subcutaneous fat layer, not
avoidable bowel interposition, extensive and/or irregular cutaneous scars, fibroid size
(<2.5 cm), number of lesions to treat (> 5 clinically significant fibroids), structure (bright
fibroids on FSE-T2w images, non-enhancing fibroids on FSE-T1w+Gd, fibroids with
heavily calcified areas) and location of the lesions (sacrum bone proximity, depth >14
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cm from the skin line), diffuse adenomyosis, uterine size (>24cm without the cervix) and
poor patient's compliance.
Of the 29 patients, 13 were technical eligible (11 were treated and 1 of the treated patients
underwent myomectomy anyway) and 16 were ineligible. Among these, 11 could avoid
undergoing pretreatment pelvic MR since one or more than one reason of ineligibility
could be detected through an accurate clinical examination and/or by ultrasound imaging.
We found 2 patients with extensive and/or irregular cutaneous scars, 2 with more than
5 clinically significant fibroids, 2 with too small fibroids, 1 peduncolated fibroid with a
small stalk, 1 asymptomatic patient, 1 with a known cervix mass, 1 patient with diffuse
adenomyosis, 1 patient with a >20cm uterine size and 1 non compliant (mentally retarded)
patient.
4 of these ineligible patients showed at least a reason of ineligibility only after
MR examination was performed (thick subcutaneous fat layer, not avoidable bowel
interposition, iso- or hyper-intense fibroids on FSE-T2w sequences and non-enhancing
fibroids on FSE-T1w+Gd).
Images for this section:
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Fig. 1: Ax FSE-T2w showing a peduncolated fibroid with a small stalk in an ineligible
patient.
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Fig. 2: Sag FSE-T1w+Gd showing a uterine length over 20 cm with multiple fibroid (only
the bigger one appreciable in the picture which is 13,5 x 11,3 x 11,4 cm in size).
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Fig. 3: Sag FATSAT-T1w+Gd showing two non enhancing (non viable) fibroids.
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Fig. 4: Sag FSE-T2w showing a very heterogeneous untreatable fibroid.
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Fig. 5: Sag FSE-T2w showing three reasons of ineligibility: - fat layer > 3cm; - intestine
in the beam path; - iso-intense fibroid.
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Fig. 6: Ax FSE-T2w showing a extensive abdominal wall scarring.
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Fig. 7: Ax FSE-T2w (same patient of figure 6) showing too many small clinically
symptomatic fibroids.
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Conclusion
In our experience MRgFUS treatment was technically possible in less than a half (44,8%)
of outpatients women with symptomatic fibroids. In 68,7% of the ineligible patients, there
was a clinical ineligibility that could have been identified by the general practitioner or
the gynecologist. Hence, we can speculate that this result is partially due to the lack of
knowledge about of MRgFUS technique among both patients and physicians.
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